Literature DB >> 12359361

Cell cycle dependence of boron uptake from two boron compounds used for clinical neutron capture therapy.

F Yoshida1, A Matsumura, Y Shibata, T Yamamoto, H Nakauchi, M Okumura, T Nose.   

Abstract

In neutron capture therapy, it is important that the boron is selectively uptaken by tumor cells. In the present study, we used flow cytometry to sort the cells in the G0/G1 phase and those in the G2/M phase, and the boron concentration in each fraction was measured with inductively coupled plasma atomic emission spectroscopy. The results revealed that sodium borocaptate and boronophenylalanine (BPA), were associated with higher rates of boron uptake in the G2/M than in the G0/G1 phase. However, the difference was more prominent in the case of BPA. The G2/M:G0/G1 ratio decreased as a function of exposure time in BPA containing culture medium, thereby indicating the cell cycle dependency of BPA uptake. Such heterogeneity of boron uptake by tumor cells should be considered for microdosimetry.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359361     DOI: 10.1016/s0304-3835(02)00380-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Analysis of boron neutron capture reaction sensitivity using Monte Carlo simulation and proposal of a new dosimetry index in boron neutron capture therapy.

Authors:  Satoshi Takeno; Hiroki Tanaka; Koji Ono; Takashi Mizowaki; Minoru Suzuki
Journal:  J Radiat Res       Date:  2022-09-21       Impact factor: 2.438

2.  DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV.

Authors:  Natsuko Kondo; Yoshinori Sakurai; Yuki Hirota; Hiroki Tanaka; Tsubasa Watanabe; Yosuke Nakagawa; Masaru Narabayashi; Yuko Kinashi; Shin-ichi Miyatake; Masatoshi Hasegawa; Minoru Suzuki; Shin-ichiro Masunaga; Takeo Ohnishi; Koji Ono
Journal:  Radiat Environ Biophys       Date:  2015-11-16       Impact factor: 1.925

3.  Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.

Authors:  Marcela A Garabalino; Elisa M Heber; Andrea Monti Hughes; Sara J González; Ana J Molinari; Emiliano C C Pozzi; Susana Nievas; Maria E Itoiz; Romina F Aromando; David W Nigg; William Bauer; Verónica A Trivillin; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2013-04-17       Impact factor: 1.925

4.  Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.

Authors:  Kunio Yokoyama; Shin-Ichi Miyatake; Yoshinaga Kajimoto; Shinji Kawabata; Atsushi Doi; Toshiko Yoshida; Tomoyuki Asano; Mitsunori Kirihata; Koji Ono; Toshihiko Kuroiwa
Journal:  J Neurooncol       Date:  2006-03-24       Impact factor: 4.130

5.  Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.

Authors:  Peng Wang; Haining Zhen; Xinbiao Jiang; Wei Zhang; Xin Cheng; Geng Guo; Xinggang Mao; Xiang Zhang
Journal:  BMC Cancer       Date:  2010-12-02       Impact factor: 4.430

6.  Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.

Authors:  Yuki Wada; Katsumi Hirose; Takaomi Harada; Mariko Sato; Tsubasa Watanabe; Akira Anbai; Manabu Hashimoto; Yoshihiro Takai
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

7.  Evaluation of the total distribution volume of 18F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling.

Authors:  Victor Romanov; Kayako Isohashi; Galal Alobthani; Rouaa Beshr; Genki Horitsugi; Yasukazu Kanai; Sadahiro Naka; Tadashi Watabe; Eku Shimosegawa; Jun Hatazawa
Journal:  Ann Nucl Med       Date:  2019-12-05       Impact factor: 2.668

8.  Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model.

Authors:  Yu-Chuan Lin; Yi-Jang Lee; Yi-Wei Chen; Shan-Ying Wang; Fong-In Chou
Journal:  Cells       Date:  2022-09-01       Impact factor: 7.666

9.  Microdosimetric Modeling of Biological Effectiveness for Boron Neutron Capture Therapy Considering Intra- and Intercellular Heterogeneity in 10B Distribution.

Authors:  Tatsuhiko Sato; Shin-Ichiro Masunaga; Hiroaki Kumada; Nobuyuki Hamada
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

10.  Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation.

Authors:  Kohei Yoshimura; Shinji Kawabata; Hideki Kashiwagi; Yusuke Fukuo; Koji Takeuchi; Gen Futamura; Ryo Hiramatsu; Takushi Takata; Hiroki Tanaka; Tsubasa Watanabe; Minoru Suzuki; Naonori Hu; Shin-Ichi Miyatake; Masahiko Wanibuchi
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.